Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C

Detalhes bibliográficos
Autor(a) principal: Fialho, Renata
Data de Publicação: 2017
Outros Autores: Pereira, Marco, Harrison, Neil, Rusted, Jennifer, Whale, Richard
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/47395
https://doi.org/10.1016/j.psychres.2017.03.049
Resumo: In this prospective study, we examined new-onset major depressive disorder (MDD) and the differential expression of depressive symptoms in a sample of 132 HCV mono-infected and 40 HIV/HCV co-infected patients initiating pegylated interferon-based treatment, including protease inhibitor therapy. The semi-structured clinical interview (SCID-I) was used to assess MDD. Severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Of the total sample, 60 patients (34.9%) developed SCID-I defined MDD during antiviral treatment. The proportion of HCV mono- and HIV/HCV patients developing MDD during treatment was not significantly different (37.9% vs. 25%; p=0.185). In both groups, there was a significant increase in HAMD total score from baseline to week 4, and a significant decrease between week 24 and 6 months post-treatment cessation. The greatest increase was observed in the symptoms of the neurovegetative syndrome. HCV mono-infected patients reported higher scores than co-infected patients, particularly impaired activity and somatic symptoms, but the differences were only significant at week 12. The finding that co-infected patients appear less vulnerable to the development of depressive symptoms during HCV treatment than HCV mono-infected patients warrants further exploration, including a thorough analysis of the biological and psychosocial factors associated with this emergence.
id RCAP_6c20ce6f0c19dc44250d4f05473cba97
oai_identifier_str oai:estudogeral.uc.pt:10316/47395
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis CAdultAntiviral AgentsCoinfectionDepressive Disorder, MajorDrug Therapy, CombinationFemaleHIV InfectionsHepacivirusHepatitis CHumansInterferon-alphaMaleMiddle AgedProspective StudiesRibavirinIn this prospective study, we examined new-onset major depressive disorder (MDD) and the differential expression of depressive symptoms in a sample of 132 HCV mono-infected and 40 HIV/HCV co-infected patients initiating pegylated interferon-based treatment, including protease inhibitor therapy. The semi-structured clinical interview (SCID-I) was used to assess MDD. Severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Of the total sample, 60 patients (34.9%) developed SCID-I defined MDD during antiviral treatment. The proportion of HCV mono- and HIV/HCV patients developing MDD during treatment was not significantly different (37.9% vs. 25%; p=0.185). In both groups, there was a significant increase in HAMD total score from baseline to week 4, and a significant decrease between week 24 and 6 months post-treatment cessation. The greatest increase was observed in the symptoms of the neurovegetative syndrome. HCV mono-infected patients reported higher scores than co-infected patients, particularly impaired activity and somatic symptoms, but the differences were only significant at week 12. The finding that co-infected patients appear less vulnerable to the development of depressive symptoms during HCV treatment than HCV mono-infected patients warrants further exploration, including a thorough analysis of the biological and psychosocial factors associated with this emergence.2017info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/47395http://hdl.handle.net/10316/47395https://doi.org/10.1016/j.psychres.2017.03.049engFialho, R., Pereira, M., Harrison, N., Rusted, J., & Whale, R. (2017). Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry Research, 253, 150-157. doi:10.1016/j.psychres.2017.03.049http://www.psy-journal.com/article/S0165-1781(16)31874-1/fulltextFialho, RenataPereira, MarcoHarrison, NeilRusted, JenniferWhale, Richardinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2020-05-25T02:24:07Zoai:estudogeral.uc.pt:10316/47395Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:48:33.370004Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
title Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
spellingShingle Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
Fialho, Renata
Adult
Antiviral Agents
Coinfection
Depressive Disorder, Major
Drug Therapy, Combination
Female
HIV Infections
Hepacivirus
Hepatitis C
Humans
Interferon-alpha
Male
Middle Aged
Prospective Studies
Ribavirin
title_short Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
title_full Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
title_fullStr Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
title_full_unstemmed Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
title_sort Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C
author Fialho, Renata
author_facet Fialho, Renata
Pereira, Marco
Harrison, Neil
Rusted, Jennifer
Whale, Richard
author_role author
author2 Pereira, Marco
Harrison, Neil
Rusted, Jennifer
Whale, Richard
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Fialho, Renata
Pereira, Marco
Harrison, Neil
Rusted, Jennifer
Whale, Richard
dc.subject.por.fl_str_mv Adult
Antiviral Agents
Coinfection
Depressive Disorder, Major
Drug Therapy, Combination
Female
HIV Infections
Hepacivirus
Hepatitis C
Humans
Interferon-alpha
Male
Middle Aged
Prospective Studies
Ribavirin
topic Adult
Antiviral Agents
Coinfection
Depressive Disorder, Major
Drug Therapy, Combination
Female
HIV Infections
Hepacivirus
Hepatitis C
Humans
Interferon-alpha
Male
Middle Aged
Prospective Studies
Ribavirin
description In this prospective study, we examined new-onset major depressive disorder (MDD) and the differential expression of depressive symptoms in a sample of 132 HCV mono-infected and 40 HIV/HCV co-infected patients initiating pegylated interferon-based treatment, including protease inhibitor therapy. The semi-structured clinical interview (SCID-I) was used to assess MDD. Severity of depressive symptoms was assessed using the Hamilton Depression Rating Scale. Of the total sample, 60 patients (34.9%) developed SCID-I defined MDD during antiviral treatment. The proportion of HCV mono- and HIV/HCV patients developing MDD during treatment was not significantly different (37.9% vs. 25%; p=0.185). In both groups, there was a significant increase in HAMD total score from baseline to week 4, and a significant decrease between week 24 and 6 months post-treatment cessation. The greatest increase was observed in the symptoms of the neurovegetative syndrome. HCV mono-infected patients reported higher scores than co-infected patients, particularly impaired activity and somatic symptoms, but the differences were only significant at week 12. The finding that co-infected patients appear less vulnerable to the development of depressive symptoms during HCV treatment than HCV mono-infected patients warrants further exploration, including a thorough analysis of the biological and psychosocial factors associated with this emergence.
publishDate 2017
dc.date.none.fl_str_mv 2017
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/47395
http://hdl.handle.net/10316/47395
https://doi.org/10.1016/j.psychres.2017.03.049
url http://hdl.handle.net/10316/47395
https://doi.org/10.1016/j.psychres.2017.03.049
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Fialho, R., Pereira, M., Harrison, N., Rusted, J., & Whale, R. (2017). Co-infection with HIV associated with reduced vulnerability to symptoms of depression during antiviral treatment for hepatitis C. Psychiatry Research, 253, 150-157. doi:10.1016/j.psychres.2017.03.049
http://www.psy-journal.com/article/S0165-1781(16)31874-1/fulltext
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133763856236544